Febuxostat Apexbio

Febuxostat

A5926-100 100 mg
EUR 595
Description: IC50: Febuxostat displayed potent mixed-type inhibition of the activity of xanthine oxidase (XO), with Ki value of 0.6 nM [1]. Febuxostat was also reported to be 1000-fold (IC50=1.8 nM) more potent than allopurinol (IC50= 2.9 ?M) at inhibiting XO-dependent uric acid formation [2].

Apexbio Reagents Laboratories manufactures the febuxostat apexbio reagents distributed by Genprice. The Febuxostat Apexbio reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Apexbio Reagents. Other Febuxostat products are available in stock. Specificity: Febuxostat Category: Apexbio

Danazol

100 mg
EUR 110
Description: Danazol showed weak androgenic effects.Danazol is a derivative of testosterone and ethisterone. An androgen is any natural or synthetic agent stimulating or controling the development and maintenance of male characteristics by binding to androgen receptors.

Danazol

250 mg
EUR 187
Description: Danazol showed weak androgenic effects.Danazol is a derivative of testosterone and ethisterone. An androgen is any natural or synthetic agent stimulating or controling the development and maintenance of male characteristics by binding to androgen receptors.

Danazol

500 mg
EUR 312
Description: Danazol showed weak androgenic effects.Danazol is a derivative of testosterone and ethisterone. An androgen is any natural or synthetic agent stimulating or controling the development and maintenance of male characteristics by binding to androgen receptors.

ML-211

1 mg
EUR 112
Description: IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas.

ML-211

10 mg
EUR 270
Description: IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas.

ML-211

25 mg
EUR 519
Description: IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas.

ML-211

5 mg
EUR 174
Description: IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas.

Human Samples information

ML-211

C3647-1 1 mg
EUR 112
Description: IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas.

ML-211

C3647-10 10 mg
EUR 270
Description: IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas.

ML-211

C3647-25 25 mg
EUR 519
Description: IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas.

ML-211

C3647-5 5 mg
EUR 174
Description: IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas.

Stachydrine (hydrochloride)

C3648-100 100 mg
EUR 119
Description: Stachydrine is an anti-metastatic agent.Stachydrine, a pyrrolidine betaine, was first isolated from seed husk and the pulp of the fruit of C. Leonurus, and many other Asian plants and fruits.

Stachydrine (hydrochloride)

C3648-1000 1 g
EUR 467
Description: Stachydrine is an anti-metastatic agent.Stachydrine, a pyrrolidine betaine, was first isolated from seed husk and the pulp of the fruit of C. Leonurus, and many other Asian plants and fruits.

Stachydrine (hydrochloride)

C3648-250 250 mg
EUR 206
Description: Stachydrine is an anti-metastatic agent.Stachydrine, a pyrrolidine betaine, was first isolated from seed husk and the pulp of the fruit of C. Leonurus, and many other Asian plants and fruits.

Stachydrine (hydrochloride)

C3648-500 500 mg
EUR 328
Description: Stachydrine is an anti-metastatic agent.Stachydrine, a pyrrolidine betaine, was first isolated from seed husk and the pulp of the fruit of C. Leonurus, and many other Asian plants and fruits.

Ceranib-2

C3649-10 10 mg
EUR 179
Description: IC50: 28 ?MCeranib-2 is an inhibitor of cellular ceramidase activity.Ceramidase catalyzes the hydrolysis of the N-acyl linkage between the fatty acid and sphingosine base in ceramide to produce sphingosine and a free fatty acid.

Ceranib-2

C3649-25 25 mg
EUR 357
Description: IC50: 28 ?MCeranib-2 is an inhibitor of cellular ceramidase activity.Ceramidase catalyzes the hydrolysis of the N-acyl linkage between the fatty acid and sphingosine base in ceramide to produce sphingosine and a free fatty acid.

Ceranib-2

C3649-5 5 mg
EUR 118
Description: IC50: 28 ?MCeranib-2 is an inhibitor of cellular ceramidase activity.Ceramidase catalyzes the hydrolysis of the N-acyl linkage between the fatty acid and sphingosine base in ceramide to produce sphingosine and a free fatty acid.

Ceranib-2

C3649-50 50 mg
EUR 595
Description: IC50: 28 ?MCeranib-2 is an inhibitor of cellular ceramidase activity.Ceramidase catalyzes the hydrolysis of the N-acyl linkage between the fatty acid and sphingosine base in ceramide to produce sphingosine and a free fatty acid.

ALK5 Inhibitor II (hydrochloride)

C3656-10 10 mg
EUR 176
Description: IC50: 4, 18, and 23 nM for ALK5 autophosphorylation, TGF-? cellular assay, and ALK5 binding in HepG2 cells, respectivelyALK5 Inhibitor II is an ALK5 inhibitor.The TGF-beta family of cytokines signal via serine/threonine kinase transmembrane type I and type II receptors.

ALK5 Inhibitor II (hydrochloride)

C3656-25 25 mg
EUR 321
Description: IC50: 4, 18, and 23 nM for ALK5 autophosphorylation, TGF-? cellular assay, and ALK5 binding in HepG2 cells, respectivelyALK5 Inhibitor II is an ALK5 inhibitor.The TGF-beta family of cytokines signal via serine/threonine kinase transmembrane type I and type II receptors.

ALK5 Inhibitor II (hydrochloride)

C3656-5 5 mg
EUR 122
Description: IC50: 4, 18, and 23 nM for ALK5 autophosphorylation, TGF-? cellular assay, and ALK5 binding in HepG2 cells, respectivelyALK5 Inhibitor II is an ALK5 inhibitor.The TGF-beta family of cytokines signal via serine/threonine kinase transmembrane type I and type II receptors.

WWL123

C3661-10 10 mg
EUR 316
Description: IC50: 0.43 ?MWWL123 is a brain-penetrant inhibitor of ABHD6.

WWL123

C3661-25 25 mg
EUR 634
Description: IC50: 0.43 ?MWWL123 is a brain-penetrant inhibitor of ABHD6.